Effectiveness and Safety of Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir in the Treatment of Moderate to Severe COVID‐19

ABSTRACT Background and Aim Simnotrelvir/ritonavir and nirmatrelvir/ritonavir are major treatments for COVID‐19, but their comparative efficacy and safety, especially in patients with moderate to severe COVID‐19, remain unclear. Methods This was a retrospective cohort study using electronic medical...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Xin Chen, Xiao‐Qing Lin, Fang Cheng, Shi‐Lin Zheng, Qiang Zhang, Te Wu, Xian‐Gao Jiang, Ji‐Chan Shi
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2025-04-01
סדרה:	Immunity, Inflammation and Disease
נושאים:	ADR clinical effectiveness COVID‐19 nirmatrelvir/ritonavir simnotrelvir/ritonavir small‐molecule antiviral drugs
גישה מקוונת:	https://doi.org/10.1002/iid3.70174
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!